Paclitaxel is a prominent cancer therapy drug with poor synthetic efficiency due to the low activity and selectivity of the hydrolases involved. Here the authors develop a TteUPO oxidase toolbox for taxane oxidation, offering an unconventional route towards paclitaxel and paclitaxel analogues.
- Mingyuan Lai
- Yu Weng
- Hui-Lei Yu
